A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias

American Journal of Geriatric Psychiatry

Volumn 8, Issue 3, 2000, Pages 221-225

  Hawkins, James W ^a   Tinkletiberg, Jared R ^b   Sheikh, Javaid I ^b   Peyser, Carol E ^b   Yesavage, Jerome A ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; DONEPEZIL; GABAPENTIN; NORTRIPTYLINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VALPROIC ACID;

ADULT; AGED; AGGRESSIVENESS; AGITATION; ARTICLE; CLINICAL ARTICLE; DEMENTIA; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MALE; NURSING HOME; PREDICTION; RATING SCALE; RETROSPECTIVE STUDY;

EID: 0033945096     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200008000-00007     Document Type: Article

References (28)

1. Ryden MB: Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord 1988; 2:342-355
2. Marx MS, Cohen-Mansfield J, Werner P: A profile of the aggressive nursing home patient. Behavior, Health, and Aging 1990; 1:65-73
3. Raskind M: A research agenda for disruptive behaviors in Alzheimer's disease. Int Psychogeriatr 1996; 8(suppl1):53-58
4. Alexopoulos GS, Silver JM, Kahn DA, et al: Treatment of agitation in older persons with dementia: The Expert Consensus Guideline Series. Postgraduate Medicine, A Special Report, April 1998
5. Hawkins JW: Non-sedating treatments for Alzheimer's patients with behavioral problems. J Clin Psychiatry 1992; 53:101-102
6. Sultzer DL, Gray KF, Gunay I, et al: A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997; 5:60-69
7. Schneider LS, Pollock VE, Lyness SA: A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
8. Katz I, Brecher M, Clyde C, Risperidone Study Group: Risperidone in the treatment of psychosis and aggressive behavior in patients with dementia. Presentation of multi-center, double blind, placebo controlled study at the Annual Meeting of the American College of Neuropsychopharmacology, Honolulu, December 1997
9. Yudofsky SC, Silver JM, Schneider SE: Pharmacologic treatment of aggression. Psychiatry Ann 1987; 17:397-406
10. Silver JM: Beta-adrenergic receptor blockers in the treatment of aggression. Currents in Affective Illness 1990; 17:5-13
11. Cantillon M, Brunswick R, Molina D, et al: Buspirone vs. haloperidol: a double-blind trial for agitation in a nursing home population with Alzheimer's disease. Am J Geriatr Psychiatry 1996; 4:263-267
12. Sakauye KM, Camp CJ, Ford PA: Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry 1993; 1:82-84
13. Gleason RP, Schneider LS: Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry 1990; 51:115-118
14. Tariot PN, Schneider LS, Katz IR: Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 1995; 8(suppl1):S28-S39
15. Herrmann N: Valproic acid treatment of agitation in dementia. Can J Psychiatry 1998; 43:69-72
16. Regan WM, Gordon SM: Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol 1997; 17:59-60
17. Ryback R, Ryback L: Gabapentin for behavioral dyscontrol (letter). Am J Psychiatry 1995; 152:1399
18. Goldenberg G, Kahaner K, Basavaragu N, et al: Gabapentin for disruptive behaviour in an elderly demented patient. Drugs Aging 1998; 13:183-184
19. Sheldon LJ, Ancill RJ, Holliday SG: Gabapentin in geriatric psychiatry patients. Can J Psychiatry 1998; 43:422-423
20. Grossman F: A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy 1998; 18:600-606
21. Kunik ME, Puryear L, Orengo CA, et al: The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1998; 13:29-34
22. Leach JP, Girvan J, Paul A, et al: Gabapentin and cognition: a double-blind, dose-ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997; 62:372-376
23. Chadwick D: Gabapentin. Lancet 1994; 343:89-91
24. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
25. Yudofsky SC, Kopecky HJ, Kunik M, et al: The Overt Agitation Severity Scale for the objective rating of agitation. J Neuropsychiatry Clin Neurosci 1997; 9:541-548
26. Cohen-Mansfield J, Marx MS, Rosenthal SA: A description of agitation in a nursing home. J Gerontol 1989; 444:M77-M84
27. Guy W: ECDEU Assessment Manual for Psychopharmacology. U.S. Department of Health, Education, and Welfare; Public Health Service; Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, 1976, pp 218-222
28. Schneider LS, Olin JT: Clinical Global Impression in Alzheimer's clinical trials. Int Psychogeriatr 1996; 8:277-290